Q-omics provides the consensus-scored LINC01134 profile across patient tissues and cancer cell-line models. LINC01134 expression is associated with patient survival in 19 of 34 cancer types, with the highest sampling consensus in ACC. Among the 18 cancer types available for tumor–normal comparison, LINC01134 is differentially expressed in 11, with the highest sampling consensus in LIHC. Additionally, LINC01134 RNA expression shows 16,784 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight ACC, LIHC, and UVM as cancer lineages where LINC01134 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for LINC01134 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes LINC01134 survival associations across molecular data types. LINC01134 RNA expression shows survival associations in the most cancer types (19). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible LINC01134 RNA expression–survival associations across cancer types. High LINC01134 expression shows unfavorable associations in ACC, LIHC, KIRC, KIRP, LGG and UVM. The ACC Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify ACC as the clearest survival context for LINC01134 RNA expression.
This table summarizes LINC01134 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 11. The strongest signals are observed in LIHC for RNA.
This table ranks reproducible tumor–normal expression differences for LINC01134. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. LINC01134 shows lower tumor expression in KICH and higher tumor expression in LIHC, LUAD, KIRC, UCEC and CHOL. The LIHC box plot shows higher LINC01134 RNA expression in tumor versus normal tissue (log2 FC = +0.566, t-test p < 0.001).
This table shows molecular features associated with LINC01134 in patient tissues and cancer cell lines. In patient samples, LINC01134 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
